+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Transdermal Hormone Replacement Therapy in Postmenopausal Women With Uterine Leiomyomas



Transdermal Hormone Replacement Therapy in Postmenopausal Women With Uterine Leiomyomas



Obstetrics & Gynecology 98(6): 1053-1058




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 067549478

Download citation: RISBibTeXText

DOI: 10.1097/00006250-200112000-00012


Related references

Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstetrics & Gynecology 98(6): 1053-1058, 2001

Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstetrics and Gynecology 98(6): 1053-1058, 2002

Effects of hormone replacement therapy on uterine leiomyomas in postmenopausal woman. Gazzetta Medica Italiana Archivio per le Scienze Mediche 161(3): 129-134, Giugno, 2002

Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas:a literature review. Climacteric 4(4): 284-292, 2001

Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review. Climacteric 4(4): 284-292, 2002

Transdermal nicotine use in postmenopausal women: does the treatment efficacy differ in women using and not using hormone replacement therapy?. Nicotine and Tobacco Research 6(5): 777-788, 2005

Transdermal nicotine use in postmenopausal women: Does the treatment efficacy differ in women using and not using hormone replacement therapy?. Nicotine & Tobacco Research 6(5): 777-788, 2004

A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas. European Journal of Obstetrics & Gynecology & Reproductive Biology 88(1): 91-94, 2000

Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 7(1): 36-41, 2000

Urinary cGMP excretion after oral and transdermal hormone replacement therapy in postmenopausal women. European Journal of Clinical Pharmacology 52(Suppl. ): A82, 1997

Transdermal hormone replacement therapy for secondary prevention of coronary artery disease in postmenopausal women. European Heart Journal 21(Abstract Suppl.): 212, August-September, 2000

Serum leptin levels and body weight in postmenopausal women under transdermal hormone replacement therapy. European Journal of Medical Research 5(2): 63-66, 2000

Insulin resistance and short-term transdermal hormone replacement therapy in hypertensive postmenopausal women. Journal of Hypertension 18(Suppl 4): S133, 2000

Oral versus transdermal hormone replacement therapy in influencing serotonin production in postmenopausal women. European Journal of Clinical Pharmacology 52(Suppl. ): A85, 1997

Effects of transdermal hormone replacement therapy on levels of soluble P- and E-selectin in postmenopausal healthy women. Fertility & Sterility 77(3): 476-480, 2002